ENTA logo

ENTA
Enanta Pharmaceuticals Inc

1,173
Mkt Cap
$360.49M
Volume
17,414.00
52W High
$17.15
52W Low
$4.09
PE Ratio
-3.25
ENTA Fundamentals
Price
$12.72
Prev Close
$12.49
Open
$12.51
50D MA
$13.79
Beta
1.04
Avg. Volume
385,474.32
EPS (Annual)
-$3.84
P/B
4.13
Rev/Employee
$544,366.67
Loading...
Loading...
News
all
press releases
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven research firms that are covering the firm, MarketBeat...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
Enanta Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections and immunological...
Business Wire·16d ago
News Placeholder
Agios Pharmaceuticals (AGIO) Surges 18.6%: Is This an Indication of Further Gains?
Agios Pharmaceuticals (AGIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Zacks·26d ago
News Placeholder
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) have received an average recommendation of "Moderate Buy" from the seven research firms that are presently covering the firm...
MarketBeat·28d ago
News Placeholder
Enanta Pharmaceuticals (ENTA) Surges 5.9%: Is This an Indication of Further Gains?
Enanta Pharmaceuticals (ENTA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
Zacks·1mo ago
News Placeholder
Enanta Pharmaceuticals (NASDAQ:ENTA) Share Price Crosses Above 200-Day Moving Average - What's Next?
Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price Passes Above 200-Day Moving Average - Should You Sell...
MarketBeat·1mo ago
News Placeholder
Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Scott Rottinghaus Sells 798 Shares
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Scott Rottinghaus sold 798 shares of Enanta Pharmaceuticals stock in a transaction that occurred on Friday, December 5th. The...
MarketBeat·2mo ago
News Placeholder
Insider Selling: Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells 1,394 Shares of Stock
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Brendan Luu sold 1,394 shares of the company's stock in a transaction dated Friday, December 5th. The shares were sold at an...
MarketBeat·2mo ago
News Placeholder
Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Sells $34,009.70 in Stock
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) insider Yat Sun Or sold 2,390 shares of Enanta Pharmaceuticals stock in a transaction that occurred on Friday, December 5th. The shares...
MarketBeat·2mo ago
News Placeholder
Enanta Pharmaceuticals (NASDAQ:ENTA) CEO Jay Luly Sells 4,743 Shares of Stock
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA - Get Free Report) CEO Jay Luly sold 4,743 shares of the business's stock in a transaction on Friday, December 5th. The stock was sold at an average price of...
MarketBeat·2mo ago
<
1
2
...
>

Latest ENTA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.